Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women
- PMID: 7863140
- DOI: 10.3109/02813439409029247
Vaginal application of lactobacilli in the prophylaxis of recurrent lower urinary tract infection in women
Abstract
Objective: To examine whether vaginal application of Lactobacillus casei v. rhamnosus reduces the reinfection rate in cystitis-prone women.
Design: A controlled, randomized, double-blind clinical trial.
Setting: Division for General Practice, University of Bergen, Norway.
Intervention: Vaginal application of lactobacilli twice weekly.
Subjects: 47 women, aged 18-50 years, reporting three or more episodes of distal urinary symptoms during the previous 12 months, of which at least one episode had been medically verified as a lower UTI.
Main outcome measure: The incidence rate of lower UTI during 6 months' follow-up.
Results: No difference in infection rate between the two groups; the incidence rate ratio between the treatment group and the placebo group was 1.41 (95% confidence interval 0.88-1.98). Lactobacilli were not found more frequently periurethrally in the treatment group than in the control group.
Conclusion: It is still uncertain whether vaginal application of lactobacilli reduces the infection rate in cystitis-prone women.
Similar articles
-
Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infection.Clin Infect Dis. 2011 May;52(10):1212-7. doi: 10.1093/cid/cir183. Epub 2011 Apr 14. Clin Infect Dis. 2011. PMID: 21498386 Free PMC article. Clinical Trial.
-
Prevalence and determinants of vaginal flora alterations in postmenopausal women.J Infect Dis. 2003 Oct 1;188(7):1054-8. doi: 10.1086/378203. Epub 2003 Sep 23. J Infect Dis. 2003. PMID: 14513427
-
The bacterial flora of the vaginal vestibule, urethra and vagina in premenopausal women with recurrent urinary tract infections.J Urol. 1981 Nov;126(5):630-4. doi: 10.1016/s0022-5347(17)54661-3. J Urol. 1981. PMID: 7029007
-
Vaginal microbiome.Ceska Gynekol. 2018 Winter;83(5):371-379. Ceska Gynekol. 2018. PMID: 30848142 Review. English.
-
Probiotics for the treatment of women with bacterial vaginosis.Clin Microbiol Infect. 2007 Jul;13(7):657-64. doi: 10.1111/j.1469-0691.2007.01688.x. Clin Microbiol Infect. 2007. PMID: 17633390 Review.
Cited by
-
Is There Evidence to Support Probiotic Use for Healthy People?Adv Nutr. 2024 Aug;15(8):100265. doi: 10.1016/j.advnut.2024.100265. Epub 2024 Jul 6. Adv Nutr. 2024. PMID: 38977065 Free PMC article. Review.
-
Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.Microbiol Spectr. 2016 Feb;4(1):10.1128/microbiolspec.UTI-0013-2012. doi: 10.1128/microbiolspec.UTI-0013-2012. Microbiol Spectr. 2016. PMID: 26999391 Free PMC article. Review.
-
The human microbiome and probiotics: implications for pediatrics.Curr Probl Pediatr Adolesc Health Care. 2008 Nov-Dec;38(10):309-27. doi: 10.1016/j.cppeds.2008.09.001. Curr Probl Pediatr Adolesc Health Care. 2008. PMID: 18992706 Free PMC article.
-
Antimicrobial activity of different Lactobacillus species against multi- drug resistant clinical isolates of Pseudomonas aeruginosa.Iran J Microbiol. 2011 Mar;3(1):21-5. Iran J Microbiol. 2011. PMID: 22347578 Free PMC article.
-
Probiotics. Some evidence of their effectiveness.Can Fam Physician. 2005 Nov;51(11):1487-93. Can Fam Physician. 2005. PMID: 16353831 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources